HEADER IMMUNE SYSTEM 10-AUG-01 1IQW TITLE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI-HUMAN FAS TITLE 2 ANTIBODY HFE7A COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTIBODY M-HFE7A, LIGHT CHAIN; COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: FAB FRAGMENT; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ANTIBODY M-HFE7A, HEAVY CHAIN; COMPND 7 CHAIN: H; COMPND 8 FRAGMENT: FAB FRAGMENT SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 STRAIN: FAS-DEFICIENT (FAS-/-); SOURCE 6 CELL_LINE: HYBRIDOMA; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 9 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 10 ORGANISM_TAXID: 10090; SOURCE 11 STRAIN: FAS-DEFICIENT (FAS-/-); SOURCE 12 CELL_LINE: HYBRIDOMA KEYWDS IMMUNOGLOBULIN, FAB, ANTI_FAS, AGONISTIC ANTIBODY, APOPTOSIS, IMMUNE KEYWDS 2 SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR S.ITO,T.TAKAYAMA,H.HANZAWA,K.ICHIKAWA,J.OHSUMI,N.SERIZAWA,T.HATA, AUTHOR 2 H.HARUYAMA REVDAT 9 30-OCT-24 1IQW 1 REMARK REVDAT 8 27-DEC-23 1IQW 1 REMARK REVDAT 7 09-OCT-19 1IQW 1 JRNL REVDAT 6 20-JUN-18 1IQW 1 AUTHOR JRNL REVDAT 5 24-FEB-09 1IQW 1 VERSN REVDAT 4 01-APR-03 1IQW 1 JRNL REVDAT 3 14-JAN-03 1IQW 1 REMARK REVDAT 2 30-JAN-02 1IQW 1 JRNL REVDAT 1 23-JAN-02 1IQW 0 JRNL AUTH S.ITO,T.TAKAYAMA,H.HANZAWA,K.ICHIKAWA,J.OHSUMI,N.SERIZAWA, JRNL AUTH 2 T.HATA,H.HARUYAMA JRNL TITL CRYSTAL STRUCTURE OF THE ANTIGEN-BINDING FRAGMENT OF JRNL TITL 2 APOPTOSIS-INDUCING MOUSE ANTI-HUMAN FAS MONOCLONAL ANTIBODY JRNL TITL 3 HFE7A. JRNL REF J.BIOCHEM. V. 131 137 2002 JRNL REFN ISSN 0021-924X JRNL PMID 11754745 JRNL DOI 10.1093/OXFORDJOURNALS.JBCHEM.A003068 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.ITO,T.TAKAYAMA,H.HANZAWA,K.ICHIKAWA,J.OHSUMI,N.SERIZAWA, REMARK 1 AUTH 2 H.HARUYAMA,T.HATA REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY CRYSTALLOGRAPHIC REMARK 1 TITL 2 STUDIES ON A FAB FRAGMENT OF THE MOUSE ANTI-HUMAN FAS REMARK 1 TITL 3 MONOCLONAL ANTIBODY HFE7A REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 57 1700 2001 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444901013208 REMARK 1 REFERENCE 2 REMARK 1 AUTH H.YOSHIDA-KATO,K.ICHIKAWA,J.YAMAGUCHI,K.WATANABE,J.OHSUMI, REMARK 1 AUTH 2 S.YONEHARA,N.SERIZAWA REMARK 1 TITL CLONING AND EXPRESSION OF A NOVEL MURINE ANTI-HUMAN FAS REMARK 1 TITL 2 ANTIBODY REMARK 1 REF BIOSCI.BIOTECHNOL.BIOCHEM. V. 64 1903 2000 REMARK 1 REFN ISSN 0916-8451 REMARK 1 REFERENCE 3 REMARK 1 AUTH K.ICHIKAWA,H.YOSHIDA-KATO,M.OHTSUKI,J.OHSUMI,J.YAMAGUCHI, REMARK 1 AUTH 2 S.TAKAHASHI,Y.TANI,M.WATANABE,A.SHIRAISHI,K.NISHIOKA, REMARK 1 AUTH 3 S.YONEHARA,N.SERIZAWA REMARK 1 TITL A NOVEL MURINE ANTI-HUMAN FAS MAB WHICH MITIGATES REMARK 1 TITL 2 LYMPHADENOPATHY WITHOUT HEPATOTOXICITY REMARK 1 REF INT.IMMUNOL. V. 12 555 2000 REMARK 1 REFN ISSN 0953-8178 REMARK 1 DOI 10.1093/INTIMM/12.4.555 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 14984 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1178 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2245 REMARK 3 BIN R VALUE (WORKING SET) : 0.2110 REMARK 3 BIN FREE R VALUE : 0.3060 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 195 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3342 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 57 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.22 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.35 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 30.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.620 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.370 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.990 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 5.520 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 7.510 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1IQW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-AUG-01. REMARK 100 THE DEPOSITION ID IS D_1000005196. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-98 REMARK 200 TEMPERATURE (KELVIN) : 296.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-6B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : DIFFRACTOMETER REMARK 200 DETECTOR MANUFACTURER : WEISSENBERG REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15256 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.04500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 32.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.09200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 10.50 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CITRATE, SODIUM BORATE, PH REMARK 280 8.50, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 296.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.71750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.88650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.98250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 66.88650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.71750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.98250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3630 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN L 216 REMARK 465 GLU L 217 REMARK 465 CYS L 218 REMARK 465 ASP H 222 REMARK 465 CYS H 223 REMARK 465 GLY H 224 REMARK 465 CYS H 225 REMARK 465 LYS H 226 REMARK 465 PRO H 227 REMARK 465 CYS H 228 REMARK 465 ILE H 229 REMARK 465 CYS H 230 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR L 31 112.13 -170.64 REMARK 500 ALA L 55 -42.52 75.41 REMARK 500 ALA L 88 -172.02 -178.38 REMARK 500 ASN L 142 70.76 42.72 REMARK 500 THR H 28 96.34 -69.59 REMARK 500 ALA H 92 -174.58 177.29 REMARK 500 ASN H 104 -9.97 79.90 REMARK 500 SER H 136 158.02 176.00 REMARK 500 ALA H 137 179.71 172.12 REMARK 500 ALA H 138 33.22 -140.74 REMARK 500 PRO H 155 -168.94 -100.39 REMARK 500 SER H 164 19.84 50.79 REMARK 500 SER H 180 46.77 72.71 REMARK 500 TRP H 196 -71.33 -59.55 REMARK 500 REMARK 500 REMARK: NULL DBREF 1IQW L 1 218 PDB 1IQW 1IQW 1 218 DBREF 1IQW H 1 230 PDB 1IQW 1IQW 1 230 SEQRES 1 L 218 ASP ILE VAL LEU THR GLN SER PRO ALA SER LEU ALA VAL SEQRES 2 L 218 SER LEU GLY GLN ARG ALA THR ILE SER CYS LYS ALA SER SEQRES 3 L 218 GLN SER VAL ASP TYR ASP GLY ASP SER TYR MET ASN TRP SEQRES 4 L 218 TYR GLN GLN LYS PRO GLY GLN PRO PRO LYS LEU LEU ILE SEQRES 5 L 218 TYR ALA ALA SER ASN LEU GLU SER GLY ILE PRO ALA ARG SEQRES 6 L 218 PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU ASN SEQRES 7 L 218 ILE HIS PRO VAL GLU GLU GLU ASP ALA ALA THR TYR TYR SEQRES 8 L 218 CYS GLN GLN SER ASN GLU ASP PRO ARG THR PHE GLY GLY SEQRES 9 L 218 GLY THR LYS LEU GLU ILE LYS ARG ALA ASP ALA ALA PRO SEQRES 10 L 218 THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU THR SEQRES 11 L 218 SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN PHE SEQRES 12 L 218 TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP GLY SEQRES 13 L 218 SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR ASP SEQRES 14 L 218 GLN ASP SER LYS ASP SER THR TYR SER MET SER SER THR SEQRES 15 L 218 LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SER SEQRES 16 L 218 TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER PRO SEQRES 17 L 218 ILE VAL LYS SER PHE ASN ARG ASN GLU CYS SEQRES 1 H 230 GLN VAL GLN LEU GLN GLN PRO GLY ALA GLU LEU VAL LYS SEQRES 2 H 230 PRO GLY ALA SER VAL LYS LEU SER CYS LYS ALA SER GLY SEQRES 3 H 230 TYR THR PHE THR SER TYR TRP MET GLN TRP VAL LYS GLN SEQRES 4 H 230 ARG PRO GLY GLN GLY LEU GLU TRP ILE GLY GLU ILE ASP SEQRES 5 H 230 PRO SER ASP SER TYR THR ASN TYR ASN GLN LYS PHE LYS SEQRES 6 H 230 GLY LYS ALA THR LEU THR VAL ASP THR SER SER SER THR SEQRES 7 H 230 ALA TYR MET GLN LEU SER SER LEU THR SER GLU ASP SER SEQRES 8 H 230 ALA VAL TYR TYR CYS ALA ARG ASN ARG ASP TYR SER ASN SEQRES 9 H 230 ASN TRP TYR PHE ASP VAL TRP GLY THR GLY THR THR VAL SEQRES 10 H 230 THR VAL SER SER ALA LYS THR THR PRO PRO SER VAL TYR SEQRES 11 H 230 PRO LEU ALA PRO GLY SER ALA ALA GLN THR ASN SER MET SEQRES 12 H 230 VAL THR LEU GLY CYS LEU VAL LYS GLY TYR PHE PRO GLU SEQRES 13 H 230 PRO VAL THR VAL THR TRP ASN SER GLY SER LEU SER SER SEQRES 14 H 230 GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER ASP LEU SEQRES 15 H 230 TYR THR LEU SER SER SER VAL THR VAL PRO SER SER THR SEQRES 16 H 230 TRP PRO SER GLN THR VAL THR CYS ASN VAL ALA HIS PRO SEQRES 17 H 230 ALA SER SER THR LYS VAL ASP LYS LYS ILE VAL PRO ARG SEQRES 18 H 230 ASP CYS GLY CYS LYS PRO CYS ILE CYS FORMUL 3 HOH *57(H2 O) HELIX 1 1 GLU L 83 ALA L 87 5 5 HELIX 2 2 SER L 125 SER L 131 1 7 HELIX 3 3 LYS L 187 GLU L 191 1 5 HELIX 4 4 THR H 28 TYR H 32 5 5 HELIX 5 5 GLN H 62 LYS H 65 5 4 HELIX 6 6 THR H 87 SER H 91 5 5 HELIX 7 7 SER H 164 SER H 166 5 3 SHEET 1 A 4 LEU L 4 SER L 7 0 SHEET 2 A 4 ALA L 19 ALA L 25 -1 O LYS L 24 N THR L 5 SHEET 3 A 4 ASP L 74 ILE L 79 -1 O LEU L 77 N ILE L 21 SHEET 4 A 4 PHE L 66 SER L 71 -1 N SER L 67 O ASN L 78 SHEET 1 B 6 SER L 10 SER L 14 0 SHEET 2 B 6 THR L 106 LYS L 111 1 O GLU L 109 N LEU L 11 SHEET 3 B 6 ALA L 88 GLN L 94 -1 N ALA L 88 O LEU L 108 SHEET 4 B 6 MET L 37 GLN L 42 0 SHEET 5 B 6 LYS L 49 TYR L 53 -1 O LYS L 49 N GLN L 41 SHEET 6 B 6 ASN L 57 LEU L 58 -1 O ASN L 57 N TYR L 53 SHEET 1 C 4 SER L 10 SER L 14 0 SHEET 2 C 4 THR L 106 LYS L 111 1 O GLU L 109 N LEU L 11 SHEET 3 C 4 ALA L 88 GLN L 94 -1 N ALA L 88 O LEU L 108 SHEET 4 C 4 THR L 101 PHE L 102 0 SHEET 1 D 2 ASP L 30 TYR L 31 0 SHEET 2 D 2 ASP L 34 SER L 35 -1 O ASP L 34 N TYR L 31 SHEET 1 E 4 THR L 118 PHE L 122 0 SHEET 2 E 4 GLY L 133 PHE L 143 -1 O VAL L 137 N PHE L 122 SHEET 3 E 4 TYR L 177 THR L 186 -1 O LEU L 185 N ALA L 134 SHEET 4 E 4 VAL L 163 TRP L 167 -1 N LEU L 164 O THR L 182 SHEET 1 F 4 SER L 157 ARG L 159 0 SHEET 2 F 4 ASN L 149 ILE L 154 -1 N ILE L 154 O SER L 157 SHEET 3 F 4 SER L 195 THR L 201 -1 O THR L 197 N LYS L 153 SHEET 4 F 4 ILE L 209 ASN L 214 -1 O ILE L 209 N ALA L 200 SHEET 1 G 4 GLN H 3 GLN H 5 0 SHEET 2 G 4 VAL H 18 SER H 25 -1 O LYS H 23 N GLN H 5 SHEET 3 G 4 THR H 78 LEU H 83 -1 O MET H 81 N LEU H 20 SHEET 4 G 4 ALA H 68 ASP H 73 -1 N THR H 71 O TYR H 80 SHEET 1 H 5 ASN H 105 TRP H 111 0 SHEET 2 H 5 ALA H 92 TYR H 102 -1 N TYR H 102 O ASN H 105 SHEET 3 H 5 MET H 34 ARG H 40 0 SHEET 4 H 5 GLY H 44 ASP H 52 -1 O GLU H 46 N LYS H 38 SHEET 5 H 5 TYR H 57 TYR H 60 -1 O ASN H 59 N GLU H 50 SHEET 1 I 4 ASN H 105 TRP H 111 0 SHEET 2 I 4 ALA H 92 TYR H 102 -1 N TYR H 102 O ASN H 105 SHEET 3 I 4 THR H 115 VAL H 119 0 SHEET 4 I 4 ALA H 9 VAL H 12 1 N VAL H 12 O THR H 118 SHEET 1 J 4 SER H 128 LEU H 132 0 SHEET 2 J 4 MET H 143 TYR H 153 -1 O LEU H 149 N TYR H 130 SHEET 3 J 4 TYR H 183 PRO H 192 -1 O TYR H 183 N TYR H 153 SHEET 4 J 4 VAL H 171 LEU H 178 -1 N HIS H 172 O SER H 188 SHEET 1 K 3 THR H 159 TRP H 162 0 SHEET 2 K 3 THR H 202 HIS H 207 -1 O ASN H 204 N THR H 161 SHEET 3 K 3 THR H 212 LYS H 217 -1 O VAL H 214 N VAL H 205 SSBOND 1 CYS L 23 CYS L 92 1555 1555 2.03 SSBOND 2 CYS L 138 CYS L 198 1555 1555 2.04 SSBOND 3 CYS H 22 CYS H 96 1555 1555 2.04 SSBOND 4 CYS H 148 CYS H 203 1555 1555 2.03 CISPEP 1 SER L 7 PRO L 8 0 -0.43 CISPEP 2 HIS L 80 PRO L 81 0 0.05 CISPEP 3 ASP L 98 PRO L 99 0 0.02 CISPEP 4 TYR L 144 PRO L 145 0 -0.41 CISPEP 5 PHE H 154 PRO H 155 0 -0.09 CISPEP 6 GLU H 156 PRO H 157 0 0.05 CRYST1 43.435 73.965 133.773 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023023 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013520 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007475 0.00000